John F. Carpenter - Search Results

Year	Number of Results
2002	13
2003	7
2004	8
2005	8
2006	7
2007	5
2008	11
2009	16
2010	14
2011	11
2012	16
2013	13
2014	21
2015	15
2016	12
2017	6
2018	10
2019	8
2020	6
2021	7
2022	5
2023	2
2024	0

1

Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.

Ross EL, Salinas A, Petty K, Her C, Carpenter JF. Ross EL, et al. Among authors: carpenter jf. Am J Health Syst Pharm. 2020 Nov 16;77(23):1980-1985. doi: 10.1093/ajhp/zxaa299. Am J Health Syst Pharm. 2020. PMID: 32974650

2

Editorial.

Carpenter JF. Carpenter JF. J Pharm Sci. 2015 Mar;104(3):778. doi: 10.1002/jps.24352. Epub 2016 Jan 8. J Pharm Sci. 2015. PMID: 28756838 No abstract available.

3

Journal of Pharmaceutical Sciences. Editorial.

Carpenter JF. Carpenter JF. J Pharm Sci. 2012 Oct;101(10):3554. doi: 10.1002/jps.23239. Epub 2012 Jun 26. J Pharm Sci. 2012. PMID: 22736509 No abstract available.

4

Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges.

Jiskoot W, Kijanka G, Randolph TW, Carpenter JF, Koulov AV, Mahler HC, Joubert MK, Jawa V, Narhi LO. Jiskoot W, et al. Among authors: carpenter jf. J Pharm Sci. 2016 May;105(5):1567-1575. doi: 10.1016/j.xphs.2016.02.031. Epub 2016 Apr 1. J Pharm Sci. 2016. PMID: 27044944 Free PMC article. Review.

5

Effects of surfaces and leachables on the stability of biopharmaceuticals.

Bee JS, Randolph TW, Carpenter JF, Bishop SM, Dimitrova MN. Bee JS, et al. Among authors: carpenter jf. J Pharm Sci. 2011 Oct;100(10):4158-70. doi: 10.1002/jps.22597. Epub 2011 Apr 26. J Pharm Sci. 2011. PMID: 21523787 Review.

6

Using X-Ray Crystallography to Simplify and Accelerate Biologics Drug Development.

Brader ML, Baker EN, Dunn MF, Laue TM, Carpenter JF. Brader ML, et al. Among authors: carpenter jf. J Pharm Sci. 2017 Feb;106(2):477-494. doi: 10.1016/j.xphs.2016.10.017. Epub 2016 Nov 23. J Pharm Sci. 2017. PMID: 27889071 Review.

7

Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics.

Verhoef JJ, Carpenter JF, Anchordoquy TJ, Schellekens H. Verhoef JJ, et al. Among authors: carpenter jf. Drug Discov Today. 2014 Dec;19(12):1945-52. doi: 10.1016/j.drudis.2014.08.015. Epub 2014 Sep 7. Drug Discov Today. 2014. PMID: 25205349 Review.

8

Working to improve healthcare for people in developing countries.

Carpenter JF. Carpenter JF. J Pharm Sci. 2008 Mar;97(3):1039-40. doi: 10.1002/jps.21247. J Pharm Sci. 2008. PMID: 18213681 No abstract available.

9

Rational design of stable lyophilized protein formulations: theory and practice.

Carpenter JF, Chang BS, Garzon-Rodriguez W, Randolph TW. Carpenter JF, et al. Pharm Biotechnol. 2002;13:109-33. doi: 10.1007/978-1-4615-0557-0_5. Pharm Biotechnol. 2002. PMID: 11987749 Review. No abstract available.

10

Preparation of active proteins, vaccines and pharmaceuticals as fine powders using supercritical or near-critical fluids.

Cape SP, Villa JA, Huang ET, Yang TH, Carpenter JF, Sievers RE. Cape SP, et al. Among authors: carpenter jf. Pharm Res. 2008 Sep;25(9):1967-90. doi: 10.1007/s11095-008-9575-6. Epub 2008 Jun 26. Pharm Res. 2008. PMID: 18581212 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

189 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year